• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官捐献增加对终末期肾病患者的健康和经济影响程度

The Magnitude of the Health and Economic Impact of Increased Organ Donation on Patients With End-Stage Renal Disease.

作者信息

Chen Huey-Fen, Ali Hayatt, Marrero Wesley J, Parikh Neehar D, Lavieri Mariel S, Hutton David W

机构信息

Department of Health Management and Policy, University of Michigan, Ann Arbor, Michigan.

Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.

出版信息

MDM Policy Pract. 2021 Dec 6;6(2):23814683211063418. doi: 10.1177/23814683211063418. eCollection 2021 Jul-Dec.

DOI:10.1177/23814683211063418
PMID:34901442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8655828/
Abstract

There are several approaches such as presumed consent and compensation for deceased donor organs that could reduce the gap between supply and demand for kidneys. Our objective is to evaluate the magnitude of the economic impact of policies to increase deceased donor organ donation in the United States. We built a Markov model and simulate an open cohort of end-stage renal disease patients awaiting kidney transplantation in the United States over 20 years. Model inputs were derived from the United States Renal Data System and published literature. We evaluate the magnitude of the health and economic impact of policies to increase deceased donor kidney donation in the United States. Increasing deceased kidney donation by 5% would save $4.7 billion, and gain 30,870 quality-adjusted life years over the lifetime of an open cohort of patients on dialysis on the waitlist for kidney transplantation. With an increase in donations of 25%, the cost saved was $21 billion, and 145,136 quality-adjusted life years were gained. Policies increasing deceased kidney donation by 5% could pay donor estates $8000 or incur a onetime cost of up to $4 billion and still be cost-saving. Increasing deceased kidney donation could significantly impact national spending and health for end-stage renal disease patients.

摘要

有几种方法,如推定同意和对已故捐赠者器官的补偿,可缩小肾脏供需之间的差距。我们的目标是评估美国增加已故捐赠者器官捐赠政策的经济影响程度。我们构建了一个马尔可夫模型,并模拟了美国20年间等待肾脏移植的终末期肾病患者的开放队列。模型输入数据来自美国肾脏数据系统和已发表的文献。我们评估了美国增加已故捐赠者肾脏捐赠政策对健康和经济的影响程度。将已故肾脏捐赠增加5%,在等待肾脏移植的透析患者开放队列的一生中可节省47亿美元,并获得30870个质量调整生命年。捐赠增加25%时,节省的成本为210亿美元,获得了145136个质量调整生命年。将已故肾脏捐赠增加5%的政策可以向捐赠者遗产支付8000美元,或承担高达40亿美元的一次性成本,且仍能节省成本。增加已故肾脏捐赠会对终末期肾病患者的国家支出和健康产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f4/8655828/aa348c94aa97/10.1177_23814683211063418-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f4/8655828/03f75a86944b/10.1177_23814683211063418-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f4/8655828/aa348c94aa97/10.1177_23814683211063418-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f4/8655828/03f75a86944b/10.1177_23814683211063418-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f4/8655828/aa348c94aa97/10.1177_23814683211063418-fig2.jpg

相似文献

1
The Magnitude of the Health and Economic Impact of Increased Organ Donation on Patients With End-Stage Renal Disease.器官捐献增加对终末期肾病患者的健康和经济影响程度
MDM Policy Pract. 2021 Dec 6;6(2):23814683211063418. doi: 10.1177/23814683211063418. eCollection 2021 Jul-Dec.
2
An ex-ante cost-utility analysis of the deemed consent legislation compared to expressed consent for kidney transplantations in Nova Scotia.新斯科舍省肾移植中推定同意立法与明示同意的事前成本效用分析。
Cost Eff Resour Alloc. 2022 Oct 6;20(1):55. doi: 10.1186/s12962-022-00390-z.
3
The Effect of State Policies on Organ Donation and Transplantation in the United States.美国国家政策对器官捐赠与移植的影响。
JAMA Intern Med. 2015 Aug;175(8):1323-9. doi: 10.1001/jamainternmed.2015.2194.
4
Estimated Association Between Organ Availability and Presumed Consent in Solid Organ Transplant.实体器官移植中器官可获得性与假定同意之间的关联估计。
JAMA Netw Open. 2019 Oct 2;2(10):e1912431. doi: 10.1001/jamanetworkopen.2019.12431.
5
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
6
Differential Willingness to Pay for Kidney Transplantation From Living and Deceased Donors: Empirical Study Among End-Stage Kidney Disease (ESKD) Patients.活体和已故供者肾移植的差异支付意愿:终末期肾病 (ESKD) 患者的实证研究。
Inquiry. 2022 Jan-Dec;59:469580221139368. doi: 10.1177/00469580221139368.
7
The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model.deceased donors: a systematic review and economic model. 存储已故捐赠者所捐肾脏方法的有效性和成本效益:一项系统综述与经济模型
Health Technol Assess. 2009 Aug;13(38):iii-iv, xi-xiv, 1-156. doi: 10.3310/hta13380.
8
Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry.英国的器官捐赠与移植:过去十年——来自英国国家移植登记处的报告。
Transplantation. 2014 Jan 15;97 Suppl 1:S1-S27. doi: 10.1097/01.TP.0000438215.16737.68.
9
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia.在澳大利亚实施“软性自愿选择”肾脏捐献系统的成本效益和预算影响分析。
Appl Health Econ Health Policy. 2022 Sep;20(5):769-779. doi: 10.1007/s40258-022-00747-8. Epub 2022 Jul 18.
10
Informing the debate: rates of kidney transplantation in nations with presumed consent.为辩论提供信息:假定同意国家的肾脏移植率。
Ann Intern Med. 2010 Nov 16;153(10):641-9. doi: 10.7326/0003-4819-153-10-201011160-00006.

引用本文的文献

1
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure.利用经济评估为肾衰竭治疗可及性相关政策提供信息的指南。
Nat Rev Nephrol. 2025 Sep 11. doi: 10.1038/s41581-025-01000-w.
2
Cadaveric training model for the endovascular management of type B aortic dissection.用于B型主动脉夹层血管内治疗的尸体训练模型
J Vasc Surg Cases Innov Tech. 2025 Jul 11;11(6):101916. doi: 10.1016/j.jvscit.2025.101916. eCollection 2025 Dec.
3
Evaluating Challenges in Access To Transplantation for Persons with HIV.

本文引用的文献

1
Estimated Association Between Organ Availability and Presumed Consent in Solid Organ Transplant.实体器官移植中器官可获得性与假定同意之间的关联估计。
JAMA Netw Open. 2019 Oct 2;2(10):e1912431. doi: 10.1001/jamanetworkopen.2019.12431.
2
Do kidney transplantations save money? A study using a before-after design and multiple register-based data from Sweden.肾移植能省钱吗?一项采用前后对比设计并利用来自瑞典的多个基于登记处数据的研究。
Clin Kidney J. 2018 Apr;11(2):283-288. doi: 10.1093/ckj/sfx088. Epub 2017 Aug 7.
3
Welsh opt-out law fails to increase organ donations.
评估艾滋病毒感染者获得移植面临的挑战。
Curr HIV/AIDS Rep. 2025 Mar 21;22(1):26. doi: 10.1007/s11904-025-00735-2.
4
A novel technique for external iliac artery reconstruction in renal transplant patients with extensively atherosclerotic lower limb vasculature.一种用于下肢血管广泛动脉粥样硬化的肾移植患者髂外动脉重建的新技术。
J Vasc Surg Cases Innov Tech. 2024 Nov 30;11(2):101698. doi: 10.1016/j.jvscit.2024.101698. eCollection 2025 Apr.
5
Adaptive Content Tuning of Social Network Digital Health Interventions Using Control Systems Engineering for Precision Public Health: Cluster Randomized Controlled Trial.使用控制系统工程对社交网络数字健康干预措施进行自适应内容调整以实现精准公共卫生:一项集群随机对照试验。
J Med Internet Res. 2023 May 31;25:e43132. doi: 10.2196/43132.
6
Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting.在澳大利亚背景下,提高原发性脑恶性肿瘤死者捐赠肾脏利用率干预措施的成本效益。
Transplant Direct. 2023 Apr 19;9(5):e1474. doi: 10.1097/TXD.0000000000001474. eCollection 2023 May.
7
Estimated Impact of Deemed Consent Legislation for Organ Donation on Individuals With Kidney Failure: A Dynamic Decision Analytic Model.推定同意器官捐赠立法对肾衰竭患者的估计影响:动态决策分析模型
Can J Kidney Health Dis. 2022 Nov 25;9:20543581221139039. doi: 10.1177/20543581221139039. eCollection 2022.
威尔士的“选择退出”法律未能增加器官捐赠。
BMJ. 2017 Dec 5;359:j5659. doi: 10.1136/bmj.j5659.
4
Population-Based Analysis and Projections of Liver Supply Under Redistricting.重新划分选区情况下肝脏供应的基于人群的分析与预测。
Transplantation. 2017 Sep;101(9):2048-2055. doi: 10.1097/TP.0000000000001785.
5
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐:第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
6
A Cost-Benefit Analysis of Government Compensation of Kidney Donors.政府对肾脏捐赠者的补偿成本效益分析。
Am J Transplant. 2016 Mar;16(3):877-85. doi: 10.1111/ajt.13490. Epub 2015 Oct 16.
7
Philosophy of organ donation: Review of ethical facets.器官捐赠的理念:伦理层面的审视
World J Transplant. 2015 Jun 24;5(2):44-51. doi: 10.5500/wjt.v5.i2.44.
8
Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs.了解接受肾脏替代治疗患者的护理成本:超越固定收费标准。
Nephrol Dial Transplant. 2015 Oct;30(10):1726-34. doi: 10.1093/ndt/gfv224. Epub 2015 Jun 11.
9
Cost-effectiveness of kidney transplantation from DCD in Italy.意大利脑死亡后器官捐献供肾移植的成本效益分析
Transplant Proc. 2014 Dec;46(10):3289-96. doi: 10.1016/j.transproceed.2014.09.146.
10
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.更新成本效益——每质量调整生命年5万美元阈值令人好奇的韧性。
N Engl J Med. 2014 Aug 28;371(9):796-7. doi: 10.1056/NEJMp1405158.